Philip Morris To Part With Inhaler Maker In Up To £258M Deal

By Law360 Staff · September 17, 2024, 2:53 PM EDT

Philip Morris International is spacing itself from the British inhaler maker it purchased in 2021 through an up to £258 million ($339.6 million) sale that preserves a commercial relationship, amid what...

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Recent Articles By Law360

September 16, 2024
King & Spalding, Winston Rep Hospice Facilities Deal
February 03, 2020
Humana Unit, PE Firm Prep $600M Medicare Practice JV
January 30, 2020
Altria Wipes Another $4.1B From Value Of Juul Stake
January 17, 2020
Davis Polk, Covington Steer Clarivate's $950M DRG Buy
December 12, 2019
Cleary Gottlieb Reps 3M In $650M Sale Of Drug Delivery Biz
December 02, 2019
Centene Sells Illinois Biz To CVS Ahead Of $17B WellCare Buy
September 26, 2019
Centene, WellCare Sell Medicaid Plans Amid $17B Deal Review
July 30, 2019
4 Firms Rep Blank Check Co. New Frontier In China's UFH Buy
May 02, 2019
3 Firms Cut $6.7B Sale Of Privately Held Wound Care Co.
March 29, 2019
Starboard Ditches Effort To Derail Bristol-Myers' $74B Buy